Zoetis on Thursday said it's naming its animal health unit Zoetis as it prepares an initial public offering of the unit. The New York-based drug maker said preparations are underway to file a potential IPO of Zoetis in order to sell a minority stake in the business to investors. Pfizer said it'll provide more details of the transaction in its second-quarter profit update.